TVTX Kronos AI forecast
A 30-trading-day price forecast for Travere Therapeutics Inc. (TVTX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Travere Therapeutics Inc. at $54.87 on 2026-12-08, +7.8% from the last close of $50.88 on 2026-10-27. Eight out of ten sampled paths end between $51.95 and $61.29, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of TVTX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $52.09 | $48.27 | $55.64 |
| 2026-11-10 | $52.60 | $49.36 | $60.05 |
| 2026-11-17 | $52.91 | $49.33 | $60.18 |
| 2026-11-24 | $52.07 | $49.58 | $62.62 |
| 2026-12-01 | $54.59 | $49.74 | $60.08 |
| 2026-12-08 | $54.87 | $51.95 | $61.29 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for TVTX?
- Kronos AI's median forecast for TVTX is $54.87 in 30 trading days, +7.8% from the last close, with a 10–90% range of $51.95 to $61.29.
- Is the TVTX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC